BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20626753)

  • 41. Homo- and Heteroassociations Drive Activation of ErbB3.
    Váradi T; Schneider M; Sevcsik E; Kiesenhofer D; Baumgart F; Batta G; Kovács T; Platzer R; Huppa JB; Szöllősi J; Schütz GJ; Brameshuber M; Nagy P
    Biophys J; 2019 Nov; 117(10):1935-1947. PubMed ID: 31653451
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3.
    McDonagh CF; Huhalov A; Harms BD; Adams S; Paragas V; Oyama S; Zhang B; Luus L; Overland R; Nguyen S; Gu J; Kohli N; Wallace M; Feldhaus MJ; Kudla AJ; Schoeberl B; Nielsen UB
    Mol Cancer Ther; 2012 Mar; 11(3):582-93. PubMed ID: 22248472
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines.
    Gollamudi M; Nethery D; Liu J; Kern JA
    Lung Cancer; 2004 Feb; 43(2):135-43. PubMed ID: 14739033
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells.
    Puricelli L; Proietti CJ; Labriola L; Salatino M; Balañá ME; Aguirre Ghiso J; Lupu R; Pignataro OP; Charreau EH; Bal de Kier Joffé E; Elizalde PV
    Int J Cancer; 2002 Aug; 100(6):642-53. PubMed ID: 12209601
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A functional comparison between the HER2(high)/HER3 and the HER2(low)/HER3 dimers on heregulin-β1-induced MMP-1 and MMP-9 expression in breast cancer cells.
    Kim S; Han J; Shin I; Kil WH; Lee JE; Nam SJ
    Exp Mol Med; 2012 Aug; 44(8):473-82. PubMed ID: 22627808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of HRG-β1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression.
    Ruan SQ; Wang SW; Wang ZH; Zhang SZ
    Mol Med Rep; 2012 Jul; 6(1):131-8. PubMed ID: 22576740
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
    Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW
    Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
    Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
    Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis.
    Weinstein EJ; Leder P
    Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trans-10,cis-12, not cis-9,trans-11, conjugated linoleic acid decreases ErbB3 expression in HT-29 human colon cancer cells.
    Cho HJ; Kim WK; Jung JI; Kim EJ; Lim SS; Kwon DY; Park JH
    World J Gastroenterol; 2005 Sep; 11(33):5142-50. PubMed ID: 16127743
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential modulation of proliferation, matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands.
    O-charoenrat P; Rhys-Evans P; Court WJ; Box GM; Eccles SA
    Clin Exp Metastasis; 1999; 17(7):631-9. PubMed ID: 10845563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Growth regulation of human breast and ovarian tumor cells by heregulin: Evidence for the requirement of ErbB2 as a critical component in mediating heregulin responsiveness.
    Lewis GD; Lofgren JA; McMurtrey AE; Nuijens A; Fendly BM; Bauer KD; Sliwkowski MX
    Cancer Res; 1996 Mar; 56(6):1457-65. PubMed ID: 8640840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.
    Jhabvala-Romero F; Evans A; Guo S; Denton M; Clinton GM
    Oncogene; 2003 Nov; 22(50):8178-86. PubMed ID: 14603258
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulin.
    Buta C; Benabou E; Lequoy M; Régnault H; Wendum D; Meratbene F; Chettouh H; Aoudjehane L; Conti F; Chrétien Y; Scatton O; Rosmorduc O; Praz F; Fartoux L; Desbois-Mouthon C
    J Exp Clin Cancer Res; 2016 Aug; 35(1):126. PubMed ID: 27514687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo knockdown of ErbB3 in mice inhibits Schwann cell precursor migration.
    Torii T; Miyamoto Y; Takada S; Tsumura H; Arai M; Nakamura K; Ohbuchi K; Yamamoto M; Tanoue A; Yamauchi J
    Biochem Biophys Res Commun; 2014 Sep; 452(3):782-8. PubMed ID: 25204498
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network.
    Weingaertner IR; Koutnik S; Ammer H
    PLoS One; 2013; 8(1):e53510. PubMed ID: 23308242
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ERBB3 knockdown induces cell cycle arrest and activation of Bak and Bax-dependent apoptosis in colon cancer cells.
    Lee H; Lee H; Chin H; Kim K; Lee D
    Oncotarget; 2014 Jul; 5(13):5138-52. PubMed ID: 24970817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling.
    Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ
    J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
    Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.